ProAssurance Merger Advances with FTC Approval
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
ProAssurance ( (PRA) ) just unveiled an announcement.
On March 19, 2025, ProAssurance Corporation and The Doctors Company entered into a merger agreement, with ProAssurance becoming a wholly owned subsidiary of The Doctors Company. The U.S. Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period on July 2, 2025, satisfying a key condition for the merger’s completion, expected in the first half of 2026. Both companies will continue to operate independently until the merger is finalized, pending remaining regulatory approvals.
The most recent analyst rating on (PRA) stock is a Hold with a $14.00 price target. To see the full list of analyst forecasts on ProAssurance stock, see the PRA Stock Forecast page.
Spark’s Take on PRA Stock
According to Spark, TipRanks’ AI Analyst, PRA is a Neutral.
ProAssurance’s overall score reflects a balance of factors. The acquisition by The Doctors Company is a significant positive, potentially leading to strategic benefits. However, high valuation metrics and cash flow issues pose risks. Technical analysis provides a mixed outlook, suggesting caution in the near term.
To see Spark’s full report on PRA stock, click here.
More about ProAssurance
ProAssurance Corporation is an industry-leading specialty insurer with extensive expertise in medical professional liability, products liability for medical technology and life sciences, and workers’ compensation insurance in the eastern U.S. The company is rated ‘A’ (Excellent) by AM Best. The Doctors Company is the nation’s largest physician-owned medical malpractice insurer, committed to advancing, protecting, and rewarding the practice of good medicine. It is part of TDC Group, serving over 110,000 healthcare professionals and organizations nationwide.
Average Trading Volume: 628,502
Technical Sentiment Signal: Buy
Current Market Cap: $1.21B
Learn more about PRA stock on TipRanks’ Stock Analysis page.
